Close
Nordic 9Nordic 9

Yonjin Venture (investor - Venture Capital)

United States yjventure.com
See something wrong or missing? Let us know
Offices:Cambridge

Yonjin Venture is an American investment firm specializing in investing in early and mid-stage life science companies.

Average round investment:12.07M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Belgium Intressa Vascular
Mostly invests in: Belgium Belgium (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Yonjin Venture

Name Criteria
Belgium Gemma Frisius Fund
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Vives Fund
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium InvestSud
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Debiopharm Innovation Fund
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France Anaxago
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Flanders Future Techfund (FFTF)
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Creathor Venture
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Wellington Partners
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Netherlands Thuja Capital Management B.V.
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Future Ventures
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top